Intervention not reported
LDL‐cholesterol atorvastatin 20 mg/d · individuals with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
LDL‐cholesterol atorvastatin 40 mg/d · individuals with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
LDL‐cholesterol atorvastatin 80 mg/d · individuals with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
WDAEb all doses · individuals with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
Systolic blood pressure · adults with primary hypertension
1 finding from 1 review
Intervention not reported
Diastolic blood pressure · adults with primary hypertension
1 finding from 1 review
Intervention not reported
Systolic blood pressure · adults with primary hypertension
1 finding from 1 review
Intervention not reported
Diastolic blood pressure · adults with primary hypertension
1 finding from 1 review
Intervention not reported
Withdrawal due to adverse effects · adults with primary hypertension
1 finding from 1 review
Intervention not reported
Decrease in systolic blood pressure · Adults with primary hypertension
1 finding from 1 review
Intervention not reported
Decrease in diastolic blood pressure · Adults with primary hypertension
1 finding from 1 review
Intervention not reported
Decrease in heart rate · Adults with primary hypertension
1 finding from 1 review
Intervention not reported
Decrease in pulse pressure · Adults with primary hypertension
1 finding from 1 review
Intervention not reported
Withdrawal due to adverse effect · Adults with primary hypertension
1 finding from 1 review
SBP (mmHg) · adults with primary hypertension
1 finding from 1 review
Diastolic blood pressure · adults with primary hypertension
1 finding from 1 review
Heart rate · adults with primary hypertension
1 finding from 1 review
Pulse pressure · adults with primary hypertension
1 finding from 1 review
Withdrawals due to adverse events · adults with primary hypertension
1 finding from 1 review
Angiotensin receptor blocker (any dose) Mean duration of 4 weeks · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
2 findings from 1 review